Back to catalog
Retatrutide 20 mg vial research vial from NV Peptides

Retatrutide

GLP-1 / GIP / Glucagon Receptor Agonist

A novel multi-agonist peptide designed to target GLP-1, GIP, and Glucagon receptors to support weight management and metabolic function.

Select size

$100.00 / 20 mg vial

Multi-Receptor Targeting

  • Targets GLP-1, GIP, and Glucagon receptors
  • Supports significant weight management
  • Improves glucose metabolism and control

Weight Management

  • Promotes appetite regulation and satiety
  • Supports reduction in body fat
  • May aid in achieving and maintaining a healthy weight

Overall Wellness

  • Supports cardiovascular health
  • May improve energy levels
  • Promotes long-term health and vitality

Studied For

Weight Management Support
Metabolic Health Support
Blood Sugar Control Support
Appetite Regulation Support
Cardiovascular Health Support
Energy & Vitality Support

Research use only. Not for human consumption. This product is not intended to diagnose, treat, cure, or prevent any disease.